P1387: TREATMENT WITH A LEUKEMIA-DERIVED DENDRITIC CELL VACCINE INDUCES INNATE AND ADAPTIVE IMMUNE RESPONSE CORRELATING WITH CLINICAL RESPONSE IN AML PATIENTS IN CR1 WITH MEASURABLE RESIDUAL DISEASE
Hester van Zeeburg,
Satwinder Kaur Singh,
Eva Wagner-Drouet,
Uwe Platzbecker,
Tobias Holderried,
Catharina VAN Elssen,
Aristoteles Giagounidis,
Bjorn Tore Gjertsen,
Arjan van de Loosdrecht,
Jeroen Rovers
Affiliations
Hester van Zeeburg
1 Mendus AB, Sweden
Satwinder Kaur Singh
1 Mendus AB, Sweden
Eva Wagner-Drouet
2 Universitätsmedizin der Johannes Gutenberg-Universität, Mainz, Germany
Uwe Platzbecker
3 Universitätsklinikum Leipzig, Leipzig, Germany
Tobias Holderried
4 Universiätsklinikum Bonn (UKB), Bonn, Germany
Catharina VAN Elssen
5 Maastricht University Medical Centre, Maastricht, The Netherlands
Aristoteles Giagounidis
6 Marien Hospital Düsseldorf, Dusseldorf, Germany
Bjorn Tore Gjertsen
7 Haukeland Universitetssykehus, Bergen, Norway
Arjan van de Loosdrecht
8 Amsterdam UMC, location VUmc, Department of Hematology, CCA, Amsterdam, The Netherlands
